Project description
New drugs that overcome antibiotic resistance may be headed for clinical trials
Gram-negative bacteria have an external membrane that prevents antibiotics from penetrating. Increasing multi-drug resistance in Gram-negative bacteria is becoming a major public health challenge and the EU-funded GNA NOW project is rising to meet it. As part of the EU's new Antimicrobial Resistance Accelerator (AMR) Programme, academic and industry experts plan to discover and test the most promising antibiotic compounds over the next six years and bring a handful of them to clinical trials.
Fields of science
Programme(s)
Funding Scheme
IMI2-RIA - Research and Innovation action
Coordinator
3521 AL Utrecht
Netherlands
See on map
Participants (11)
22419 Hamburg
See on map
69486 Lyon Cedex 03
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
69007 Lyon
See on map
38124 Braunschweig
See on map
BS10 5NB Bristol
See on map
L69 7ZX Liverpool
See on map
75654 Paris
See on map
Legal entity other than a subcontractor which is affiliated or legally linked to a participant. The entity carries out work under the conditions laid down in the Grant Agreement, supplies goods or provides services for the action, but did not sign the Grant Agreement. A third party abides by the rules applicable to its related participant under the Grant Agreement with regard to eligibility of costs and control of expenditure.
86034 Poitiers Cedex
See on map
3015 GD Rotterdam
See on map
1090 Wien
See on map
80686 Munchen
See on map